CHARM: COVID-19 Health Action Response for Marines-Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test.
Saved in:
| Title: | CHARM: COVID-19 Health Action Response for Marines-Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test. |
|---|---|
| Authors: | Sedegah M; Agile Vaccines and Therapeutics Department, Naval Medical Research Center, Silver Spring, MD, United States of America., Porter C; Virology Department, Naval Medical Research Center, Silver Spring, MD, United States of America., Hollingdale MR; Agile Vaccines and Therapeutics Department, Naval Medical Research Center, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation, Bethesda, MD, United States of America., Ganeshan H; Agile Vaccines and Therapeutics Department, Naval Medical Research Center, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation, Bethesda, MD, United States of America., Huang J; Agile Vaccines and Therapeutics Department, Naval Medical Research Center, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation, Bethesda, MD, United States of America., Goforth CW; Virology Department, Naval Medical Research Center, Silver Spring, MD, United States of America., Belmonte M; Agile Vaccines and Therapeutics Department, Naval Medical Research Center, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation, Bethesda, MD, United States of America., Belmonte A; Agile Vaccines and Therapeutics Department, Naval Medical Research Center, Silver Spring, MD, United States of America.; GDIT, MD, United States of America., Weir DL; Virology Department, Naval Medical Research Center, Silver Spring, MD, United States of America., Lizewski RA; U.S. Naval Medical Research Unit SIX, Lima, Perú., Lizewski SE; U.S. Naval Medical Research Unit SIX, Lima, Perú., Sealfon SC; Icahn School of Medicine at Mount Sinai, New York, NY, United States of America., Jani V; Virology Department, Naval Medical Research Center, Silver Spring, MD, United States of America.; Henry M. Jackson Foundation, Bethesda, MD, United States of America., Cheng Y; Virology Department, Naval Medical Research Center, Silver Spring, MD, United States of America.; Leidos, Reston, VA, United States of America., Inoue S; Agile Vaccines and Therapeutics Department, Naval Medical Research Center, Silver Spring, MD, United States of America.; GDIT, MD, United States of America., Velasco R; Agile Vaccines and Therapeutics Department, Naval Medical Research Center, Silver Spring, MD, United States of America., Villasante E; Agile Vaccines and Therapeutics Department, Naval Medical Research Center, Silver Spring, MD, United States of America., Sun P; Virology Department, Naval Medical Research Center, Silver Spring, MD, United States of America., Letizia AG; Virology Department, Naval Medical Research Center, Silver Spring, MD, United States of America. |
| Source: | PloS one [PLoS One] 2022 Apr 07; Vol. 17 (4), pp. e0266691. Date of Electronic Publication: 2022 Apr 07 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0266691 |
